Skip to content
BidBenchmark
SolicitationAmendment 2

Levalbuterol HCL Solution

DLA TROOP SUPPORT

Response status

Historical record

Apr 18, 2022, 7:00 PM UTC

This notice is no longer open.

Posted
Apr 1, 2022
Archive date
Mar 7, 2028
SAM status
Active
This is a preserved solicitation record. The response window is closed because the published deadline passed.

Answer-first brief

What the source record says

  • DLA TROOP SUPPORT published this solicitation.
  • The notice uses NAICS 325412 (Pharmaceutical Preparation Manufacturing).

Procurement identity

Notice ID
18344f562fae415fb53b28c0c12410b8
Solicitation
SPE2D221R0116
Base type
Solicitation
Version
2 of 2

Solicitation facts

Structured fields from the current SAM notice version. A dash means the source did not publish a value.

Notice type
Solicitation
Solicitation number
SPE2D221R0116
Set-aside
Set-aside code
Posted
Apr 1, 2022
Responses due
Apr 18, 2022, 7:00 PM UTC
Archive date
Mar 7, 2028
Archive type
autocustom
Base type
Solicitation
Organization type
OFFICE
Benchmark category
Category confidence
Category source
Last seen
Aug 29, 2026

Buyer and place

Office hierarchy and place of performance as published.

Department
DEPT OF DEFENSE
Department code
Subagency
Defense Logistics Agency
Subagency code
Office
DLA TROOP SUPPORT
Organization path
Organization path codes
Office address
PHILADELPHIA, PA, 19111, USA
Place of performance
City code
State
State code
Postal code
Country

Points of contact

Contact details from the current notice version.

Notice description

Source text reproduced without an AI summary.

Amendment 0005 is issued to extend the closing date from April 04, 2022 to April 18, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0004 is issued to extend the closing date from March 21, 2022 to April 04, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0003 is issued to add the 30 count Vials per case to subject solicitation and amend solicitation pages as an attachment. Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time) Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description. SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation

Comparable award range

Historical award values for work matched by the fixed rubric—not an estimate of this opportunity.

No past awards scored highly enough to form a comparable range.

Comparable awards

The match score is decomposed so each comparison can be challenged.

No comparable awards are attached to this notice.

Amendment history

A version is preserved whenever the normalized notice contents change.

VersionNotice typeObservedResponses dueContent hash
1SolicitationAug 10, 2026Apr 18, 2022, 7:00 PM UTCa3b8443cf7aa75ce
2SolicitationAug 28, 2026Apr 18, 2022, 7:00 PM UTC089912b5afbdbe89

Record provenance

Field-level lineage for the current opportunity version.

FieldSourceSource as ofParserTransform
agency_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_dateSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
base_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
contactsSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
descriptionSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
naics_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_idSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_citySAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_country_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_postal_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_state_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
organization_typeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
posted_dateSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
psc_codeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
response_deadlineSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
sam_urlSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
solicitation_numberSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
subagency_nameSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
titleSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3
upstream_activeSAM.gov Contract OpportunitiesAug 10, 2026sam_opportunity_snapshot@2026.08.22026.08.3

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

  1. 1Notice fields come from the SAM.gov contract opportunities record last seen Aug 29, 2026. SAM.gov remains authoritative.

Note 1 covers the solicitation record. No synthetic FAQ or inferred solicitation value is published.

Levalbuterol HCL Solution — federal contract opportunity · BidBenchmark